All other authors have declared no conflicts of interest.ADepartment of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka-Sayama, JapanīDepartment of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of KoreaĬLiver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, ChinaĭDepartment of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, ChinaĮDivision of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, TaiwanįInstitute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan Oya: Honoraria (self), Research grant / Funding (self): Pfizer Honoraria (self), Research grant / Funding (self): Novartis Honoraria (self), Advisory / Consultancy: Bayer Honoraria (self): Ono Honoraria (self): BMS. Human japanese intermediate trial full#Kamei: Full / Part-time employment: Pfizer R&D Japan. Fujii: Full / Part-time employment: Pfizer R&D Japan. Advisory / Consultancy, Research grant / Funding (institution): Genentech/Roche Advisory / Consultancy: Incyte Research grant / Funding (institution): Bristol-Myers Squibb (BMS) Advisory / Consultancy, Research grant / Funding (institution): Novartis Advisory / Consultancy, Research grant / Funding (institution): Exelixis Advisory / Consultancy, Research grant / Funding (institution): Eisai Advisory / Consultancy: Merck. Motzer: Advisory / Consultancy, Research grant / Funding (institution): Pfizer, Inc. Uemura: Honoraria (self), Advisory / Consultancy, Research grant / Funding (self): Ono Honoraria (self), Speaker Bureau / Expert testimony: BMS Honoraria (self), Research grant / Funding (self): AstraZeneca Honoraria (self), Speaker Bureau / Expert testimony: MSD Honoraria (self), Speaker Bureau / Expert testimony, Research grant / Funding (self): Janssen Advisory / Consultancy: Sanofi Speaker Bureau / Expert testimony, Research grant / Funding (self): Pfizer Speaker Bureau / Expert testimony: Bayer Research grant / Funding (self): Taiho Research grant / Funding (self): Astellas Research grant / Funding (self): Ono. Eto: Honoraria (self), Advisory / Consultancy, Research grant / Funding (self): Ono Honoraria (self), Advisory / Consultancy: BMS Honoraria (self), Advisory / Consultancy, Research grant / Funding (self): Pfizer Honoraria (self), Advisory / Consultancy, Research grant / Funding (self): Novartis Honoraria (self), Research grant / Funding (self): Bayer. Honoraria (self): Chugai Pharmaceutical Co., Ltd. Honoraria (self): TAIHO Pharmaceutical Co., Ltd. Honoraria (self): Novartis Pharma K.K Honoraria (self): ONO Pharmaceutical Co., Ltd. Numakura: Honoraria (self): Pfizer Honoraria (self): Astellas Honoraria (self): Ono Pharm Honoraria (self): Kyowa Kirin Honoraria (self): AstraZeneca Research grant / Funding (self): Grants-in-Aid for Scientific Research, the ministry of Education, Japan. Kanayama: Honoraria (self), Research grant / Funding (institution): Pfizer. Hatakeyama: Honoraria (self), Research grant / Funding (institution): Pfizer Honoraria (self), Research grant / Funding (institution): Astellas Honoraria (self), Research grant / Funding (institution): Kissei Honoraria (self), Research grant / Funding (institution): Sanofi Honoraria (self), Research grant / Funding (institution): Ono Research grant / Funding (institution): Bristol Research grant / Funding (institution): Janssen Research grant / Funding (institution): Kaneka. Tomita: Honoraria (self), Research grant / Funding (institution): Pfizer Honoraria (self), Research grant / Funding (institution): Astellas Honoraria (self), Advisory / Consultancy: Novartis Honoraria (self), Advisory / Consultancy, Research grant / Funding (institution): Ono Honoraria (self): Sanofi-Aventis Honoraria (self): BMS Advisory / Consultancy: Taiho Advisory / Consultancy: MSD Research grant / Funding (institution): Takeda.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |